Project Details
Description
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft vs. Host Disease
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/16 → 6/30/22 |
Funding
- H. LEE MOFFITT CANCER CENTER & RESEARCH
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.